Enario, Noli P.

HRN: 23-75-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2025
CEFUROXIME 1.5GM (VIAL)
04/01/2025
04/01/2025
IV
1.5g
1 Hr Prior To OR
For Elective OR
Waiting Final Action 
04/02/2025
MUPIROCIN 2%, 15G (TUBE)
04/02/2025
04/09/2025
TOPICAL
Apply Generously
TID
S/P Excision Of Nasoalveolar Mass Right Nostril
Waiting Final Action 
04/02/2025
CEFUROXIME 750MG (VIAL)
04/02/2025
04/09/2025
IVTT
750mg
Q8
S/P Excision Via Caldwell Approach
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: